Fidia Farmaceutici S.p.A.
"Our company is already present in many geographical areas of the world. The founding of the new company in Austria is part of the Group's expansion strategy and its innovative pharmaceutical solutions, moving into markets offering us new and interesting opportunities,"
Carlo Pizzocaro, CEO of Fidia Farmaceutici
The objective of the new company is to explore and leverage business opportunities arising in the new Central European markets as well as to expand its offering by introducing new pharmacological solutions for regenerative medicine.